Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 168,198 | 0 | 0 | 0 | 63,250 |
| Marketable Securities | 42,008 | 0 | 0 | 0 | 35,380 |
| Other current assets | 0 | 0 | 0 | 0 | 1,461 |
| TOTAL | $212,278 | $0 | $0 | $0 | $100,091 |
| Non-Current Assets | |||||
| PPE Net | 130 | N/A | N/A | N/A | 299 |
| Other Non-Current Assets | 2,300 | 0 | 0 | 0 | 188 |
| TOTAL | $2,430 | $N/A | $N/A | $N/A | $487 |
| Total Assets | $214,708 | $0 | $0 | $0 | $100,461 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,679 | 0 | 0 | 0 | 934 |
| Accrued Expenses | 4,641 | 0 | 0 | 0 | 1,589 |
| TOTAL | $14,320 | $0 | $0 | $0 | $2,523 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 834 | 1,456 | 5,253 | 190 | 137,847 |
| TOTAL | $74 | $N/A | $N/A | $N/A | $137,847 |
| Total Liabilities | $14,394 | $0 | $0 | $0 | $140,370 |
| Shareholders' Equity | |||||
| Common Shares | 3 | 0 | 0 | 0 | 0 |
| Retained earnings | -93,339 | 0 | 0 | 0 | -41,540 |
| Other shareholders' equity | 1,302 | 0 | 0 | 0 | 861 |
| TOTAL | $200,314 | $0 | $0 | $0 | $-39,909 |
| Total Liabilities And Equity | $214,708 | $0 | $0 | $0 | $100,461 |